Clear cell adenocarcinoma of the urethra: review of the literature.
Venyo AK.
Int J Surg Oncol. 2015;2015:790235. doi: 10.1155/2015/790235. Epub 2015 Jan 20.
Skene gland adenocarcinoma of the urethra: A systematic review.
Li XH, Zhang YT.
Asian J Surg. 2024 Mar;47(3):1587-1588. doi: 10.1016/j.asjsur.2023.12.023. Epub 2023 Dec 14.
Mucinous adenocarcinoma of the prostatic urethra after brachytherapy.
Isharwal S, Gupta S, Ortiz N, Greene KL.
Int Urol Nephrol. 2023 Jun;55(6):1477-1479. doi: 10.1007/s11255-023-03518-z. Epub 2023 Feb 16.
Female Urethra Adenocarcinoma.
Dell'Atti L, Galosi AB.
Clin Genitourin Cancer. 2018 Apr;16(2):e263-e267. doi: 10.1016/j.clgc.2017.10.006. Epub 2017 Oct 16.
Primary mucinous cell adenocarcinoma of female urethra.
Banthia R, Singh UP, Danish N, Lal H.
BMJ Case Rep. 2022 Oct 19;15(10):e248507. doi: 10.1136/bcr-2021-248507.
Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.
Zhao T, Chuang HW, Cornejo KM, Crotty RK, Dahl DM, Wszolek MF, Zlatev DV, Zietman AL, Wu CL.
Hum Pathol. 2022 Oct;128:101-109. doi: 10.1016/j.humpath.2022.07.018. Epub 2022 Aug 1.
Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra.
Paner GP, Lopez-Beltran A, Amin MB.
Am J Surg Pathol. 2021 Apr 1;45(4):543-549. doi: 10.1097/PAS.0000000000001635.
Primary mucinous adenocarcinoma of the urethra: A clinicopathological analysis of 35 cases.
Ge R, Zhang J, Lu M, Shi Y, Yan S, Xue Z, Wang Z, Lopez-Beltran A, Cheng L.
Histopathology. 2024 Apr;84(5):753-764. doi: 10.1111/his.15118. Epub 2023 Dec 19.
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations.
Song B, Lee SH, Park JH, Moon KC.
Cancer Res Treat. 2024 Jan;56(1):280-293. doi: 10.4143/crt.2023.577. Epub 2023 Sep 11.
Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients.
Alrohaibani A, Osunkoya AO.
Pathol Res Pract. 2024 Apr;256:155273. doi: 10.1016/j.prp.2024.155273. Epub 2024 Mar 28.
